I think with replicel's current work, the best we can hope for is that they improve efficacy in their dose escalating trials, maybe getting to around 20% regrowth or something. One thing that would be great is if the dermal sheath cup cells they use migrate to local follicles and provide some dht protection, so effectively it would be a long term preventative measure at least. I've seen hints of that mode of action in their videos, but obviously they haven't done long term studies yet to see if hair keeps falling out after a number off years.
8th World Congress For Hair Research - Korea (2014)
Collapse
X
-
Maybe they have something promising.Comment
-
I've actually got more faith in Histogen than Replicel, mainly because it would allow a combination of an HT plus Histogen's HSC injections for maintenance as well as some regrowth. That would be enough for everyone in the early stages. The growth factors would overpower the effects of DHT and render it useless. Much better than daily Finasteride or daily topical application of CB.Comment
-
Something happened there at close doors, my guess is they expected better results that leaded to substantial regrowth.
Maybe Arashi is right and we should focuse more on the implications of Jahoda and Tsuji findings and the excitings new pathways opened by those breakthroughs.Comment
-
I think the attention should be equal to both because I have no desire to wait 10+ years for any of the recent developments to turn into a commercial treatment. That's too long.Comment
-
I've actually got more faith in Histogen than Replicel, mainly because it would allow a combination of an HT plus Histogen's HSC injections for maintenance as well as some regrowth. That would be enough for everyone in the early stages. The growth factors would overpower the effects of DHT and render it useless. Much better than daily Finasteride or daily topical application of CB.
If Histogen were available it would replace any need for finasteride.
It would benefit the whole range of norwood classes, and would make HTs a much more appealing and more viable option.
This would expand the HT market, benefiting both doctors and patients.
Some might say we don't know how effective Histogen is past the 2 year mark, but the same could have been said for finasteride at the date of its FDA approval. They didn't know how long that would be effective either. Time will tell.Comment
-
Comment
-
I've actually got more faith in Histogen than Replicel, mainly because it would allow a combination of an HT plus Histogen's HSC injections for maintenance as well as some regrowth. That would be enough for everyone in the early stages. The growth factors would overpower the effects of DHT and render it useless. Much better than daily Finasteride or daily topical application of CB.
Also these new findings in May look promising, especially with several companies on the ball with it. Look forward to hearing reports from the conference.Comment
-
-
I personally would rather use something like CB 03 01 topically then have to get injections into my head. If both work I am going with the topicalComment
Comment